These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 10853185)

  • 21. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Advances in gene therapy for intervertebral disc degeneration.
    Chadderdon RC; Shimer AL; Gilbertson LG; Kang JD
    Spine J; 2004; 4(6 Suppl):341S-347S. PubMed ID: 15541687
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gene therapy for rheumatoid arthritis.
    Bessis N; Doucet C; Cottard V; Douar AM; Firat H; Jorgensen C; Mezzina M; Boissier MC
    J Gene Med; 2002; 4(6):581-91. PubMed ID: 12439850
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gene therapy for rheumatoid arthritis.
    Burstein H
    Curr Opin Mol Ther; 2001 Aug; 3(4):362-74. PubMed ID: 11525560
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gene therapy in musculoskeletal repair.
    Nixon AJ; Goodrich LR; Scimeca MS; Witte TH; Schnabel LV; Watts AE; Robbins PD
    Ann N Y Acad Sci; 2007 Nov; 1117():310-27. PubMed ID: 18056051
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ex vivo gene delivery of IL-1Ra and soluble TNF receptor confers a distal synergistic therapeutic effect in antigen-induced arthritis.
    Kim SH; Lechman ER; Kim S; Nash J; Oligino TJ; Robbins PD
    Mol Ther; 2002 Nov; 6(5):591-600. PubMed ID: 12409257
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Gene therapy in rheumatoid arthritis: new aspects].
    Pundt N; Peters MA; Wunrau C; Pap T
    Dtsch Med Wochenschr; 2008 Aug; 133(34-35):1737-41. PubMed ID: 18696407
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Progress toward skeletal gene therapy.
    Klamut HJ; Chen ST; Lau KH; Baylink DJ
    Crit Rev Eukaryot Gene Expr; 2004; 14(1-2):89-136. PubMed ID: 15104530
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bone tissue engineering by gene delivery.
    Kofron MD; Laurencin CT
    Adv Drug Deliv Rev; 2006 Jul; 58(4):555-76. PubMed ID: 16790291
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Technology evaluation: MFG-IRAP, University of Pittsburgh.
    Baragi VM
    Curr Opin Mol Ther; 2000 Apr; 2(2):216-20. PubMed ID: 11249645
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Gene therapy for osteoarticular disorders].
    Gouze JN; Evans CH; Ghivizzani SC; Gouze E
    Med Sci (Paris); 2007 Mar; 23(3):303-9. PubMed ID: 17349293
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Experimental gene therapy in models of inflammatory arthritis].
    Bessis N; Fournier C; Fradelizi D; Boissier MC
    C R Seances Soc Biol Fil; 1996; 190(1):159-63. PubMed ID: 8881276
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enhanced gene transfer to arthritic joints using adeno-associated virus type 5: implications for intra-articular gene therapy.
    Adriaansen J; Tas SW; Klarenbeek PL; Bakker AC; Apparailly F; Firestein GS; Jorgensen C; Vervoordeldonk MJ; Tak PP
    Ann Rheum Dis; 2005 Dec; 64(12):1677-84. PubMed ID: 15878906
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The promise of a new clinical trial--intra-articular IL-1 receptor antagonist.
    Evans CH; Robbins PD
    Proc Assoc Am Physicians; 1996 Jan; 108(1):1-5. PubMed ID: 8834057
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Amphoteric liposomes enable systemic antigen-presenting cell-directed delivery of CD40 antisense and are therapeutically effective in experimental arthritis.
    Andreakos E; Rauchhaus U; Stavropoulos A; Endert G; Wendisch V; Benahmed AS; Giaglis S; Karras J; Lee S; Gaus H; Bennett CF; Williams RO; Sideras P; Panzner S
    Arthritis Rheum; 2009 Apr; 60(4):994-1005. PubMed ID: 19333921
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel approach for gene therapy: engraftment of fibroblasts containing the artificial chromosome expression system at the site of inflammation.
    Adriaansen J; Vervoordeldonk MJ; Vanderbyl S; de Jong G; Tak PP
    J Gene Med; 2006 Jan; 8(1):63-71. PubMed ID: 16038012
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The SCID mouse model: novel therapeutic targets - lessons from gene transfer.
    Pierer M; Müller-Ladner U; Pap T; Neidhart M; Gay RE; Gay S
    Springer Semin Immunopathol; 2003 Aug; 25(1):65-78. PubMed ID: 12904892
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of cytokines in osteoarthritis pathophysiology.
    Fernandes JC; Martel-Pelletier J; Pelletier JP
    Biorheology; 2002; 39(1-2):237-46. PubMed ID: 12082286
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The 2003 Nicolas Andry Award. Orthopaedic gene therapy.
    Evans CH; Ghivizzani SC; Robbins PD
    Clin Orthop Relat Res; 2004 Dec; (429):316-29. PubMed ID: 15577504
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nucleic acid-based modulation of cardiac gene expression for the treatment of cardiac diseases. Approaches and perspectives.
    Poller W; Fechner H; Kurreck J; Pauschinger M; Kühl U; Erdmann VA; Lamers JM; Schultheiss HP
    Z Kardiol; 2004 Mar; 93(3):171-93. PubMed ID: 15024585
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.